Publicacions (71) Publicacions de María Remedios Alemán Valls

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 1

  3. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV

    Emerging Microbes and Infections, Vol. 13, Núm. 1

2023

  1. Dermoscopy of monkeypox: Histopathology and clinical correlation

    Journal of the European Academy of Dermatology and Venereology

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. Adaptación del rotatorio de especialidades médicas al entorno virtual debido a la pandemia por COVID-19: análisis de resultados

    InnoEduca Tic 2021: Libro de Actas de las VIII Jornadas Iberoamericanas de Innovación Educativa en el ámbito de las TIC y las TAC Las Palmas de Gran Canaria, 18 y 19 de noviembre de 2021

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment

    AIDS (London, England), Vol. 35, Núm. 8, pp. 1283-1293

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

  4. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

    AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507

2019

  1. Ideación suicida y depresión en pacientes VIH+: Estudio transversal sobre prevalencia y factores de riesgo

    Revista Multidisciplinar del Sida, Vol. 7, Núm. 16, pp. 20-34

2018

  1. Desprendimiento del epitelio pigmentario de la retina en la retinopatía por malaria

    Archivos de la Sociedad Española de Oftalmologia, Vol. 93, Núm. 8, pp. 406-410

  2. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

    AIDS, Vol. 32, Núm. 11, pp. 1423-1430

  3. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  4. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  2. Prognostic value of acute delirium recovery in older adults

    Geriatrics and Gerontology International, Vol. 17, Núm. 8, pp. 1161-1167